Mamedica is a London, UK-based medical cannabis clinic which was founded in 2021 and launched in 2022.[ citation needed] It is one of four UK clinics licensed to prescribe and dispense medical cannabis.[ citation needed]
In August 2022, it published a survey of 4,000 people which found that 60% of British people would consider using cannabis to treat medical conditions, particularly if prescribed by a doctor. [1] [2] A February 2023 survey for Mamedica found a third of respondents would use medical marijuana to help treat depression. [3]
In June 2023, Mamedica announced a strategic UK partnership with Canadian medical cannabis products supplier 4C Labs. [4]
The clinic has reported a 400% increase in patients since it was founded. [5] Robson says the clinic aims "to offer an alternative to conventional medicines to individuals who are struggling with a severe medical condition and desire to regain a sense of normalcy in their daily lives". [6]
Mamedica is a member of the UK's Cannabis Industry Council. [7]
Since June 2022, 40% of Mamedica's prescriptions have been for mental health conditions, including anxiety, depression, stress, insomnia and post-traumatic stress disorder. [8] In 2023, Mamedica reported an increase in demand from patients suffering from psychiatric conditions and opting to use medical cannabis as a replacement for traditional medication that can cause side effects. [9]
In addition, the clinic prescribes CBD to support patients with menopause symptoms like hot flushes, [10] and the clinic supports patients living with chronic neurological pain, with bespoke cannabis-based prescription medicines (CBPMs) that improve individuals' overall quality of life by reducing symptoms of depression and anxiety. [11]
While more than 89,000 private medical cannabis prescriptions have been made in the UK, there have been fewer than five medical cannabis prescriptions via the NHS. [12] UK legislation states that a prescription for medical cannabis can only be initiated by a specialist consultant on the General Medical Council (GMC) register. [13] Before patients can book a Mamedica consultation, they need to have tried at least two licensed medications or treatments and must not have any history of schizophrenia or psychosis. [14] Patients must provide their medical records and details about their family medical history to mitigate any potential risks of using CBPMs. [14]
Mamedica doctors can prescribe CBPMs including THC, Cannabidiol (CBD) and balanced cannabis profiles and cannabis flower, oil, capsules and cartridges for patients living with chronic conditions. [15] Mamedica's cannabis flower prescriptions are strictly for use in dry-herb vaporisers, devices that let patients heat the flower and inhale its contents as a vapour. [14]
Mamedica is a London, UK-based medical cannabis clinic which was founded in 2021 and launched in 2022.[ citation needed] It is one of four UK clinics licensed to prescribe and dispense medical cannabis.[ citation needed]
In August 2022, it published a survey of 4,000 people which found that 60% of British people would consider using cannabis to treat medical conditions, particularly if prescribed by a doctor. [1] [2] A February 2023 survey for Mamedica found a third of respondents would use medical marijuana to help treat depression. [3]
In June 2023, Mamedica announced a strategic UK partnership with Canadian medical cannabis products supplier 4C Labs. [4]
The clinic has reported a 400% increase in patients since it was founded. [5] Robson says the clinic aims "to offer an alternative to conventional medicines to individuals who are struggling with a severe medical condition and desire to regain a sense of normalcy in their daily lives". [6]
Mamedica is a member of the UK's Cannabis Industry Council. [7]
Since June 2022, 40% of Mamedica's prescriptions have been for mental health conditions, including anxiety, depression, stress, insomnia and post-traumatic stress disorder. [8] In 2023, Mamedica reported an increase in demand from patients suffering from psychiatric conditions and opting to use medical cannabis as a replacement for traditional medication that can cause side effects. [9]
In addition, the clinic prescribes CBD to support patients with menopause symptoms like hot flushes, [10] and the clinic supports patients living with chronic neurological pain, with bespoke cannabis-based prescription medicines (CBPMs) that improve individuals' overall quality of life by reducing symptoms of depression and anxiety. [11]
While more than 89,000 private medical cannabis prescriptions have been made in the UK, there have been fewer than five medical cannabis prescriptions via the NHS. [12] UK legislation states that a prescription for medical cannabis can only be initiated by a specialist consultant on the General Medical Council (GMC) register. [13] Before patients can book a Mamedica consultation, they need to have tried at least two licensed medications or treatments and must not have any history of schizophrenia or psychosis. [14] Patients must provide their medical records and details about their family medical history to mitigate any potential risks of using CBPMs. [14]
Mamedica doctors can prescribe CBPMs including THC, Cannabidiol (CBD) and balanced cannabis profiles and cannabis flower, oil, capsules and cartridges for patients living with chronic conditions. [15] Mamedica's cannabis flower prescriptions are strictly for use in dry-herb vaporisers, devices that let patients heat the flower and inhale its contents as a vapour. [14]